Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc. Synovial sarcoma (SyS) is an aggressive neoplasm driven by the SS18–SSX fusion, and is characterized by low T cell infiltration. Here, we studied the cancer–immune interplay in SyS using an integrative approach that comb...
Main Author: | |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2022
|
Online Access: | https://hdl.handle.net/1721.1/134031.2 |